Brasofensine

Chemical structure of Brasofensine

Brasofensine is a pharmacological compound that has been investigated for its potential use in the treatment of Parkinson's disease and other neurological disorders. It is classified as a dopamine reuptake inhibitor, which means it works by blocking the reabsorption of dopamine into neurons, thereby increasing the availability of dopamine in the synaptic cleft.

Mechanism of Action

Brasofensine primarily acts by inhibiting the dopamine transporter (DAT), which is responsible for the reuptake of dopamine from the synaptic cleft back into the presynaptic neuron. By blocking this transporter, brasofensine increases the concentration of dopamine in the synaptic cleft, enhancing dopaminergic neurotransmission. This mechanism is particularly beneficial in conditions like Parkinson's disease, where there is a deficiency of dopamine in the striatum.

Potential Therapeutic Uses

Parkinson's Disease

Parkinson's disease is a progressive neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the substantia nigra. The resulting dopamine deficiency leads to the hallmark symptoms of Parkinson's, including tremor, rigidity, and bradykinesia. By increasing dopamine levels, brasofensine has the potential to alleviate these symptoms.

Other Neurological Disorders

In addition to Parkinson's disease, brasofensine has been studied for its effects on other neurological conditions that involve dopaminergic dysfunction, such as attention deficit hyperactivity disorder (ADHD) and certain forms of depression. However, its efficacy and safety in these conditions require further investigation.

Development and Research

Brasofensine was initially developed by NeuroSearch, a Danish pharmaceutical company, and underwent several clinical trials to assess its safety and efficacy. Despite promising preclinical results, the development of brasofensine was eventually discontinued due to various challenges encountered during clinical trials, including issues related to efficacy and side effects.

Chemical Properties

Brasofensine is a synthetic compound with a complex chemical structure, as depicted in the accompanying image. Its molecular formula is C16H23NO2, and it belongs to the class of compounds known as piperidines.

Related Pages

• Dopamine reuptake inhibitor
• Parkinson's disease
• Dopamine
• Neurotransmitter